AI In Cancer Diagnostics Market Report 2026
AI In Cancer Diagnostics Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

AI In Cancer Diagnostics Market Report 2026

Global Outlook – By Component (Software Solutions, Hardware, Services), By Cancer Type (Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer And Cervical Cancer, Prostate And Colorectal Cancer, Other Cancer Types), By Application (Screening And Diagnosis, Tumor Identification, Monitoring), By End User (Hospitals, Diagnostic Centers, Medical Research Institutes) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

AI In Cancer Diagnostics Market Overview

• AI In Cancer Diagnostics market size has reached to $0.79 billion in 2025

• Expected to grow to $1.97 billion in 2030 at a compound annual growth rate (CAGR) of 19.9%

• Growth Driver: Rising Cancer Cases Propel Advances Artificial Intelligence Takes Center Stage In Cancer Diagnostics

• Market Trend: AI-Driven Pathology Solutions Transform Cancer Diagnosis in Europe

North America was the largest region in 2025.

What Is Covered Under AI In Cancer Diagnostics Market?

AI in cancer diagnostics refers to the use of artificial intelligence technologies, such as machine learning and deep learning, to analyze medical images, genetic data, or patient histories to assist in the early detection, diagnosis, and prognosis of cancer. These systems can recognize patterns and anomalies in data that might be imperceptible to humans, increasing diagnostic accuracy and efficiency.

The main types of components of AI in cancer diagnostics are software solutions, hardware, and services. Software solutions refer to the use of artificial intelligence (AI) and machine learning (ML) technologies to improve the accuracy and efficiency of cancer detection, prognosis, and treatment selection. The various types of cancer include breast cancer, lung cancer, brain tumor, skin cancer and cervical cancer, prostate and colorectal cancer, and others. These are used in various applications such as screening and diagnosis, tumor identification, and monitoring and also by various end users such as hospitals, diagnostic centers, medical research institutes, and contract research organizations.

AI In Cancer Diagnostics Market Global Report 2026 Market Report bar graph

What Is The AI In Cancer Diagnostics Market Size and Share 2026?

The ai in cancer diagnostics market size has grown exponentially in recent years. It will grow from $0.79 billion in 2025 to $0.96 billion in 2026 at a compound annual growth rate (CAGR) of 20.2%. The growth in the historic period can be attributed to limited ai adoption in early diagnostic workflows, reliance on traditional imaging techniques, increasing cancer prevalence worldwide, rising demand for early detection solutions, expansion of diagnostic centers.

What Is The AI In Cancer Diagnostics Market Growth Forecast?

The ai in cancer diagnostics market size is expected to see rapid growth in the next few years. It will grow to $1.97 billion in 2030 at a compound annual growth rate (CAGR) of 19.9%. The growth in the forecast period can be attributed to advancements in deep learning and machine learning algorithms, growth of ai-powered imaging systems, increasing integration of predictive analytics in healthcare, rising investments in digital health technologies, collaboration between ai developers and medical institutions. Major trends in the forecast period include growing adoption of AI-based imaging and diagnostic tools, integration of predictive analytics in cancer screening, rising use of ai for tumor identification and classification, expansion of AI-driven monitoring and follow-up systems, increasing collaboration between hospitals and ai solution providers.

Customer representative image Book your 30 minutes free consultation with our research experts

Global AI In Cancer Diagnostics Market Segmentation

1) By Component: Software Solutions, Hardware, Services

2) By Cancer Type: Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer And Cervical Cancer, Prostate And Colorectal Cancer, Other Cancer Types

3) By Application: Screening And Diagnosis, Tumor Identification, Monitoring

4) By End User: Hospitals, Diagnostic Centers, Medical Research Institutes

Subsegments:

1) By Software Solutions: Machine Learning Software, Deep Learning Software, Image Analysis Software

2) By Hardware: AI-Powered Imaging Systems, Diagnostic Devices

3) By Services: AI Integration Services, Consulting And Training Services, Support And Maintenance Services

What Is The Driver Of The AI In Cancer Diagnostics Market?

The increasing prevalence of cancer is expected to propel the growth of artificial intelligence in the cancer diagnostics market going forward. Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. The integration of AI in cancer care aims to enhance efficiency, accuracy, and personalized treatment options, ultimately improving outcomes for cancer patients. For instance, in May 2024, according to the National Cancer Institute, a US-based Government agency, In 2024, approximately 2 million new cancer cases are expected to be diagnosed in the U.S., with over 611,000 deaths projected. By 2040, new cancer cases are estimated to rise to 29.9 million globally, with cancer-related deaths increasing to 15.3 million. Therefore, the increasing prevalence of cancer is driving the growth of artificial intelligence in the cancer diagnostics market.

Key Players In The Global AI In Cancer Diagnostics Market

Major companies operating in the ai in cancer diagnostics market are Microsoft Corporation, IBM Corporation, Verily Life Sciences LLC, Tempus Labs Inc, Guardant Health Inc, Lunit Inc, Paige AI Inc, Viz.ai Inc, Enlitic Inc, Ibex Medical Analytics Ltd, Kheiron Medical Technologies Limited, CureMetrix Inc, CancerIQ Inc, MultiplAI Health Inc, Freenome Holdings Inc, SkinVision B V, Owkin Inc, Imagen Technologies Inc, Cyrcadia Health Inc, Oncora Medical Inc, Xilis Inc

Global AI In Cancer Diagnostics Market Trends and Insights

Major companies operating in the AI in cancer diagnostics market are experiencing significant growth due to advancements in AI-powered digital pathology solutions for cancer diagnosis. AI-powered digital pathology solutions for cancer diagnosis refer to the use of artificial intelligence (AI) algorithms to detect cancer and other diagnostic features in multiple tissue types, providing accurate and timely cancer diagnosis, support case prioritization, and reproducible diagnoses. For instance, In November 2023, Dedalus & Ibex Medical Analytics, a Europe-based health software company, launched an integrated End-to-End AI-powered digital pathology solution for cancer diagnosis across Europe. This solution aims to improve accuracy, provide AI-powered decision support tools, streamline reporting, enhance laboratory efficiency, and increase diagnostic confidence.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The AI In Cancer Diagnostics Market?

In December 2023, Lunit, a South Korean-based AI company, acquired Volpara for $193 million. This acquisition is expected to position the combined entity as a leading force in AI-driven cancer diagnostics, particularly in the U.S. market, due to Volpara's strong presence in over 2,000 medical sites across the U.S. and its extensive database of over 100 million high-quality mammogram images. The acquisition is contingent upon Volpara shareholders' and New Zealand High Court's approval. Volpara is a New Zealand-based company that provides AI-powered software for personalized screening and early detection of breast cancer.

Regional Outlook

North America was the largest region in the artificial intelligence in cancer diagnostics market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the AI In Cancer Diagnostics Market?

AI in the cancer diagnostics market consists of revenues earned by entities by providing services such as early detection and screening, image analysis and interpretation, predictive analytics, and treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in Cancer Diagnostics market also consists of sales of medical imaging devices, pathology analysis systems, genomic sequencing equipment, and patient monitoring devices that are used in providing services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the AI In Cancer Diagnostics Market Report 2026?

The ai in cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ai in cancer diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

AI In Cancer Diagnostics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $0.96 billion
Revenue Forecast In 2035 $1.97 billion
Growth Rate CAGR of 20.2% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Component, Cancer Type, Application, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Microsoft Corporation, IBM Corporation, Verily Life Sciences LLC, Tempus Labs Inc, Guardant Health Inc, Lunit Inc, Paige AI Inc, Viz.ai Inc, Enlitic Inc, Ibex Medical Analytics Ltd, Kheiron Medical Technologies Limited, CureMetrix Inc, CancerIQ Inc, MultiplAI Health Inc, Freenome Holdings Inc, SkinVision B V, Owkin Inc, Imagen Technologies Inc, Cyrcadia Health Inc, Oncora Medical Inc, Xilis Inc
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. AI In Cancer Diagnostics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global AI In Cancer Diagnostics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. AI In Cancer Diagnostics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global AI In Cancer Diagnostics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Biotechnology, Genomics & Precision Medicine

4.2. Major Trends

4.2.1 Growing Adoption Of Ai-Based Imaging And Diagnostic Tools

4.2.2 Integration Of Predictive Analytics In Cancer Screening

4.2.3 Rising Use Of Ai For Tumor Identification And Classification

4.2.4 Expansion Of Ai-Driven Monitoring And Follow-Up Systems

4.2.5 Increasing Collaboration Between Hospitals And Ai Solution Providers

5. AI In Cancer Diagnostics Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Diagnostic Centers

5.3 Medical Research Institutes

5.4 Contract Research Organizations

5.5 Oncology Clinics

6. AI In Cancer Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global AI In Cancer Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global AI In Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global AI In Cancer Diagnostics Market Size, Comparisons And Growth Rate Analysis

7.3. Global AI In Cancer Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global AI In Cancer Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global AI In Cancer Diagnostics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. AI In Cancer Diagnostics Market Segmentation

9.1. Global AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Software Solutions, Hardware, Services

9.2. Global AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer And Cervical Cancer, Prostate And Colorectal Cancer, Other Cancer Types

9.3. Global AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Screening And Diagnosis, Tumor Identification, Monitoring

9.4. Global AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Diagnostic Centers, Medical Research Institutes

9.5. Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Machine Learning Software, Deep Learning Software, Image Analysis Software

9.6. Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

AI-Powered Imaging Systems, Diagnostic Devices

9.7. Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

AI Integration Services, Consulting And Training Services, Support And Maintenance Services

10. AI In Cancer Diagnostics Market Regional And Country Analysis

10.1. Global AI In Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global AI In Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific AI In Cancer Diagnostics Market

11.1. Asia-Pacific AI In Cancer Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific AI In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China AI In Cancer Diagnostics Market

12.1. China AI In Cancer Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China AI In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India AI In Cancer Diagnostics Market

13.1. India AI In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan AI In Cancer Diagnostics Market

14.1. Japan AI In Cancer Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan AI In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia AI In Cancer Diagnostics Market

15.1. Australia AI In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia AI In Cancer Diagnostics Market

16.1. Indonesia AI In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea AI In Cancer Diagnostics Market

17.1. South Korea AI In Cancer Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea AI In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan AI In Cancer Diagnostics Market

18.1. Taiwan AI In Cancer Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan AI In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia AI In Cancer Diagnostics Market

19.1. South East Asia AI In Cancer Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia AI In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe AI In Cancer Diagnostics Market

20.1. Western Europe AI In Cancer Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe AI In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK AI In Cancer Diagnostics Market

21.1. UK AI In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany AI In Cancer Diagnostics Market

22.1. Germany AI In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France AI In Cancer Diagnostics Market

23.1. France AI In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy AI In Cancer Diagnostics Market

24.1. Italy AI In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain AI In Cancer Diagnostics Market

25.1. Spain AI In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe AI In Cancer Diagnostics Market

26.1. Eastern Europe AI In Cancer Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe AI In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia AI In Cancer Diagnostics Market

27.1. Russia AI In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America AI In Cancer Diagnostics Market

28.1. North America AI In Cancer Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America AI In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA AI In Cancer Diagnostics Market

29.1. USA AI In Cancer Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA AI In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada AI In Cancer Diagnostics Market

30.1. Canada AI In Cancer Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada AI In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America AI In Cancer Diagnostics Market

31.1. South America AI In Cancer Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America AI In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil AI In Cancer Diagnostics Market

32.1. Brazil AI In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East AI In Cancer Diagnostics Market

33.1. Middle East AI In Cancer Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East AI In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa AI In Cancer Diagnostics Market

34.1. Africa AI In Cancer Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa AI In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. AI In Cancer Diagnostics Market Regulatory and Investment Landscape

36. AI In Cancer Diagnostics Market Competitive Landscape And Company Profiles

36.1. AI In Cancer Diagnostics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. AI In Cancer Diagnostics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. AI In Cancer Diagnostics Market Company Profiles

36.3.1. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.2. IBM Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Verily Life Sciences LLC Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Tempus Labs Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Guardant Health Inc Overview, Products and Services, Strategy and Financial Analysis

37. AI In Cancer Diagnostics Market Other Major And Innovative Companies

Lunit Inc, Paige AI Inc, Viz.ai Inc, Enlitic Inc, Ibex Medical Analytics Ltd, Kheiron Medical Technologies Limited, CureMetrix Inc, CancerIQ Inc, MultiplAI Health Inc, Freenome Holdings Inc, SkinVision B V, Owkin Inc, Imagen Technologies Inc, Cyrcadia Health Inc, Oncora Medical Inc

38. Global AI In Cancer Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The AI In Cancer Diagnostics Market

40. AI In Cancer Diagnostics Market High Potential Countries, Segments and Strategies

40.1 AI In Cancer Diagnostics Market In 2030 - Countries Offering Most New Opportunities

40.2 AI In Cancer Diagnostics Market In 2030 - Segments Offering Most New Opportunities

40.3 AI In Cancer Diagnostics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global AI In Cancer Diagnostics Market, Overview Of Key Products - Product Examples
  • Table 2: Global AI In Cancer Diagnostics Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global AI In Cancer Diagnostics Market, Supply Chain Analysis
  • Table 4: Global AI In Cancer Diagnostics Market, Major Raw Material Providers
  • Table 5: Global AI In Cancer Diagnostics Market, Major Resource Providers
  • Table 6: Global AI In Cancer Diagnostics Market, Major Manufacturers (Suppliers)
  • Table 7: Global AI In Cancer Diagnostics Market, Major Distributors And Channel Partners
  • Table 8: Global AI In Cancer Diagnostics Market, Key Technologies & Future Trends
  • Table 9: Global AI In Cancer Diagnostics Market, Major Trends
  • Table 10: Global AI In Cancer Diagnostics Market, Major End Users
  • Table 11: Global AI In Cancer Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global AI In Cancer Diagnostics Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global AI In Cancer Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global AI In Cancer Diagnostics Market - TAM, US$ Billion, 2025
  • Table 15: Global AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global AI In Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global AI In Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global AI In Cancer Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global AI In Cancer Diagnostics Market - Company Scoring Matrix
  • Table 98: Microsoft Corporation Financial Performance
  • Table 99: IBM Corporation Financial Performance
  • Table 100: Verily Life Sciences LLC Financial Performance
  • Table 101: Tempus Labs Inc Financial Performance
  • Table 102: Guardant Health Inc Financial Performance
  • Table 103: Global AI In Cancer Diagnostics Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global AI In Cancer Diagnostics Market, Competitive Dashboard
  • Table 105: Global AI In Cancer Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, AI In Cancer Diagnostics Market Size Gain ($ Billion), Segmentation By Component, 2025 – 2030
  • Table 107: Global, AI In Cancer Diagnostics Market Size Gain ($ Billion), Segmentation By Cancer Type, 2025 – 2030
  • Table 108: Global, AI In Cancer Diagnostics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

    Figure 1: Global AI In Cancer Diagnostics Market, Overview Of Key Products - Product Examples
  • Figure 2: Global AI In Cancer Diagnostics Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global AI In Cancer Diagnostics Market, Supply Chain Analysis
  • Figure 4: Global AI In Cancer Diagnostics Market, Major Raw Material Providers
  • Figure 5: Global AI In Cancer Diagnostics Market, Major Resource Providers
  • Figure 6: Global AI In Cancer Diagnostics Market, Major Manufacturers (Suppliers)
  • Figure 7: Global AI In Cancer Diagnostics Market, Major Distributors And Channel Partners
  • Figure 8: Global AI In Cancer Diagnostics Market, Key Technologies & Future Trends
  • Figure 9: Global AI In Cancer Diagnostics Market, Major Trends
  • Figure 10: Global AI In Cancer Diagnostics Market, Major End Users
  • Figure 11: Global AI In Cancer Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global AI In Cancer Diagnostics Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global AI In Cancer Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global AI In Cancer Diagnostics Market - TAM, US$ Billion, 2025
  • Figure 15: Global AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global AI In Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global AI In Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global AI In Cancer Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global AI In Cancer Diagnostics Market - Company Scoring Matrix
  • Figure 98: Microsoft Corporation Financial Performance
  • Figure 99: IBM Corporation Financial Performance
  • Figure 100: Verily Life Sciences LLC Financial Performance
  • Figure 101: Tempus Labs Inc Financial Performance
  • Figure 102: Guardant Health Inc Financial Performance
  • Figure 103: Global AI In Cancer Diagnostics Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global AI In Cancer Diagnostics Market, Competitive Dashboard
  • Figure 105: Global AI In Cancer Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, AI In Cancer Diagnostics Market Size Gain ($ Billion), Segmentation By Component, 2025 – 2030
  • Figure 107: Global, AI In Cancer Diagnostics Market Size Gain ($ Billion), Segmentation By Cancer Type, 2025 – 2030
  • Figure 108: Global, AI In Cancer Diagnostics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Frequently Asked Questions

The AI In Cancer Diagnostics market was valued at $0.79 billion in 2025, increased to $0.96 billion in 2026, and is projected to reach $1.97 billion by 2030.

The global AI In Cancer Diagnostics market is expected to grow at a CAGR of 19.9% from 2026 to 2035 to reach $1.97 billion by 2035.

Some Key Players in the AI In Cancer Diagnostics market Include, Microsoft Corporation, IBM Corporation, Verily Life Sciences LLC, Tempus Labs Inc, Guardant Health Inc, Lunit Inc, Paige AI Inc, Viz.ai Inc, Enlitic Inc, Ibex Medical Analytics Ltd, Khei

Major trend in this market includes: AI-Driven Pathology Solutions Transform Cancer Diagnosis in Europe. For further insights on this market. request a sample here

North America was the largest region in the artificial intelligence in cancer diagnostics market in 2025. The regions covered in the ai in cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North Ame

Customer representative image Book your 30 minutes free consultation with our research experts